Pathway enrichment KEGG (Figure 4) uncovered that the DEMs predicted targets were primarily involved in metabolic pathways; Pathways in cancer (Figure S1), PI3K-Akt Pathway (Figure S2), and MAPK signaling pathway (Figure S3). The gene discussed is AKT1; the disease is cancer.